Novartis CAR-T cell therapy CTL019 receives FDA Breakthrough … – PR Newswire (press release)
|
Novartis CAR-T cell therapy CTL019 receives FDA Breakthrough …
PR Newswire (press release) EAST HANOVER, N.J., April 18, 2017 /PRNewswire/ — Novartis announced today that the US Food and Drug Administration (FDA) has granted Breakthrough … |
